InvestorsHub Logo
Followers 425
Posts 20207
Boards Moderated 1
Alias Born 02/22/2010

Re: $heff post# 93261

Friday, 05/27/2016 7:46:15 AM

Friday, May 27, 2016 7:46:15 AM

Post# of 97237
$BCLI $10 valuation as
NurOwn™ Phase 2 Clinical Trial Data to be Reported in Mid 2016


http://s1.q4cdn.com/460208960/files/News/2016/May-17-2016_BCLI_Bautz.pdf?utm_content=bufferbd490&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer


$BCLI A key P2 trial of NurOwn in Amyotrophic Lateral Sclerosis (ALS) will be complete by the end of April. Results expected by mid-year.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.